Biocon (English Wikipedia)

"Biocon Limited To Build US$161 Million R&D Facility in Bio-XCell, Malaysia". Asian Scientist Magazine | Science, technology and medical news updates from Asia. 11 September 2011. Retrieved 8 February 2018.

biocon.com

"Biocon Q4FY24 Revenue at Rs 3,966 Cr, EBITDA at Rs 964 Cr; Net Profit (before exceptional items) at Rs 144 Cr". Biocon. 16 May 2024. Retrieved 17 May 2024.
"Biocon Annual Report 2017" (PDF). Biocon.
"Biocon Annual Report, 2010" (PDF). Archived from the original (PDF) on 26 October 2010. Retrieved 20 September 2010.
"Active Pharmaceutical Ingredient (API)". Biocon. 3 July 2020. Retrieved 26 December 2022.
Biocon Website ("Biocon - Biosimilars, Fermentation, Oral Insulin, Human Insulin, Immunosuppresants, Monoclonal Antibody, Recombinant Proteins, Biopharmaceutical, Biotechnology Company, EGFR, GCSF, Fermentation, Orlistat, Insulin Glargine, Insulin Lispro, Peptides, Insulin Aspart". Archived from the original on 7 August 2014. Retrieved 3 August 2014.)
"Press Release titled "Biocon Biologics and Viatris Inc. Receive Historic Approval for First Interchangeable Biosimilar Semglee® (insulin glargine-yfgn injection) for the Treatment of Diabetes"" (PDF). Biocon.com. 2021. Retrieved 22 March 2022.
Biocon (16 September 2021). "Biocon Biologics and Serum Institute Life Sciences Announce Strategic Alliance". Biocon. Retrieved 23 April 2022.

biosimilardevelopment.com

"Biocon Wins MYR 300 Million Contract For Insulin From MoH Malaysia". www.biosimilardevelopment.com. Retrieved 20 December 2017.

books.google.com

Baisya, Rajat K. (9 September 2010). Winning Strategies for Business. SAGE Publications India. ISBN 9788132106081.
Pearce (2009). Strategic Management 10E. McGraw-Hill Education (India) Pvt Limited. ISBN 9780070264380.
Burns, Lawton R. (13 January 2014). India's Healthcare Industry: Innovation in Delivery, Financing, and Manufacturing. Cambridge University Press. ISBN 9781107044371.

brandindiapharma.in

"Biocon Ltd: About Biocon Pharma Company Founder, CEO, Products & Contact Address". www.brandindiapharma.in. Retrieved 8 February 2018.

business-standard.com

Das, Sohini (17 September 2021). "Biocon Biologics, Serum Institute Life Sciences enter strategic alliance". Business Standard India. Retrieved 23 March 2022.

doi.org

Plum-Mörschel, Leona; Singh, Gursharan; Murugesan, Sundara Moorthi Nainar; Marwah, Ashwani; Panda, Jayanti; Loganathan, Subramanian; Athalye, Sandeep N. (2022). "Pharmacokinetic and pharmacodynamic equivalence of Biocon's biosimilar Insulin-R with the US -licensed Humulin® R formulation in healthy subjects: Results from the RHINE -1 ( Recombinant Human INsulin Equivalence-1 ) study". Diabetes, Obesity and Metabolism. 24 (4): 713–721. doi:10.1111/dom.14635. ISSN 1462-8902. PMC 9303355. PMID 34981621.
"Atlas Copco sells majority stake in rental business". Pump Industry Analyst. 2006 (10): 12. 29 October 2006. doi:10.1016/s1359-6128(06)71621-4. ISSN 1359-6128.

dx.doi.org

"Atlas Copco sells majority stake in rental business". Pump Industry Analyst. 2006 (10): 12. 29 October 2006. doi:10.1016/s1359-6128(06)71621-4. ISSN 1359-6128.

evaluategroup.com

"Dr. APJ Abdul Kalam Dedicates India\'s First Cancer Drug BIOMab EGFR to the Nation and Inaugurates India\'s Largest Biotech-Hub "Biocon Park" | Evaluate". www.evaluategroup.com. Retrieved 8 February 2018.
"Biocon Acquires 70% Stake in German Pharmaceutical Company, AxiCorp: Biosimilars Will be Main Focus | Evaluate". www.evaluategroup.com. Retrieved 8 February 2018.

fiercebiotech.com

"Indian CRO Syngene sets up Amgen R&D center in Bangalore | FierceBiotech". www.fiercebiotech.com. 6 September 2016. Retrieved 8 February 2018.

flipit.money

"Biocon incorporates wholly-owned subsidiary Biofusion Therapeutics". flipit.money. Retrieved 20 March 2023.

forbes.com

Egan, Mary Ellen. "Big Shot in Bangalore". Forbes. Retrieved 7 March 2021.

fortuneindia.com

Ghosh, Debojyoti (2021). "Syngene's winning formula". www.fortuneindia.com. Retrieved 15 March 2022.

hdfcsec.com

Rughani, Kushal (10 February 2021). "Initiating Coverage: Syngene International Ltd" (PDF). HDFC Securities. p. 2. Retrieved 22 April 2022.

icicidirect.com

Khandekar, Siddhant; Thakur, Raunak (21 January 2022). "Syngene International (SYNINT)" (PDF). ICICI Direct. p. 2. Retrieved 17 May 2022.

iclg.com

Li, Robert (2 March 2022). "Viatris sells biosimilars unit for USD 3.335 billion". ICLG. Retrieved 31 March 2022.

indianmirror.com

nimmi. "Biocon, India's largest biotech company". www.indianmirror.com. Retrieved 8 February 2018.

indiatimes.com

timesofindia.indiatimes.com

"Kiran Mazumdar-Shaw's Biocon develops new breast cancer drug". The Times of India. 18 January 2014. Retrieved 19 January 2014.

livemint.com

Pilla, Viswanath (24 December 2015). "Biocon launches hepatitis-C drug in India". livemint.com/. Retrieved 8 February 2018.
Pilla, Viswanath (15 July 2016). "Biocon's partner FUJIFILM launches insulin glargine in Japan". livemint.com/. Retrieved 20 December 2017.
Trivedi, Isha (2 December 2017). "US FDA approves Mylan-Biocon's biosimilar for cancer drug Herceptin". livemint.com/. Retrieved 8 February 2018.
Rajagopal, Divya (1 March 2022). "Biocon's unit buys biosimilar assets of Viatris for $3.34 billion". mint. Retrieved 22 March 2022.
Jaiswar, Pooja Sitaram (6 September 2022). "Biocon divests over ₹1,220 crore stake in Syngene International in bulk deal". mint. Retrieved 8 September 2022.

medicaldialogues.in

business.medicaldialogues.in

"Biocon, Mylan get European Commission approval to market biosimilar insulin glargine". Business Medical Dialogues. 30 March 2018.
"Biocon appoints Christiane Hamacher as CEO of Biocon Biologics India". Medical Dialogues. 2 March 2019.
"Biocon names Siddharth Mittal as new CEO, Joint MD; bids farewell to Arun Chandavarkar". Medical Dialogues. 3 December 2019.

moneycontrol.com

"Biocon Consolidated Balance Sheet, Biocon Financial Statement & Accounts". www.moneycontrol.com. Retrieved 31 July 2020.

mylan.com

newsroom.mylan.com

"Mylan Announces Strategic Collaboration with Biocon to Enter the Global Generic Biologics Market". MediaRoom. Retrieved 8 February 2018.

nih.gov

ncbi.nlm.nih.gov

Plum-Mörschel, Leona; Singh, Gursharan; Murugesan, Sundara Moorthi Nainar; Marwah, Ashwani; Panda, Jayanti; Loganathan, Subramanian; Athalye, Sandeep N. (2022). "Pharmacokinetic and pharmacodynamic equivalence of Biocon's biosimilar Insulin-R with the US -licensed Humulin® R formulation in healthy subjects: Results from the RHINE -1 ( Recombinant Human INsulin Equivalence-1 ) study". Diabetes, Obesity and Metabolism. 24 (4): 713–721. doi:10.1111/dom.14635. ISSN 1462-8902. PMC 9303355. PMID 34981621.

pubmed.ncbi.nlm.nih.gov

Plum-Mörschel, Leona; Singh, Gursharan; Murugesan, Sundara Moorthi Nainar; Marwah, Ashwani; Panda, Jayanti; Loganathan, Subramanian; Athalye, Sandeep N. (2022). "Pharmacokinetic and pharmacodynamic equivalence of Biocon's biosimilar Insulin-R with the US -licensed Humulin® R formulation in healthy subjects: Results from the RHINE -1 ( Recombinant Human INsulin Equivalence-1 ) study". Diabetes, Obesity and Metabolism. 24 (4): 713–721. doi:10.1111/dom.14635. ISSN 1462-8902. PMC 9303355. PMID 34981621.

novartis.com

"Sandoz announces exclusive global collaboration with Biocon on next-generation biosimilars | Novartis". Novartis. Retrieved 8 February 2018.

nytimes.com

"How India's Mother of Invention Built an Industry", 16 August 2003

outlookmoney.com

Kiran Mazumdar-Shaw, CMD, Biocon Ltd, 'Biotech Is Not for Punters', Outlook Money, 15 July 2004

prnewswire.com

Abbott. "Abbott Announces Collaboration with Syngene to Open First Nutrition R&D Center in India". prnewswire.com (Press release). Retrieved 8 February 2018.

syngeneintl.com

"SynVent Integrated Drug Discovery". Syngene International. Retrieved 24 July 2022.

thebetterindia.com

Katyal, Surabhi (15 June 2015). "6 Indian and Indian Origin Women in the list of Forbes 100 Most Powerful Women in the World". The Better India. Retrieved 21 September 2024.

thehindubusinessline.com

"Biocon unveils biologic drug to treat skin disorder". @businessline. Retrieved 8 February 2018.
"Christiane Hamacher quits as CEO of Biocon Biologics". BusinessLine. 22 January 2021. Retrieved 21 September 2024.
Babu, Venkatesha (2021). "We are co-innovating with global pharma companies: Syngene MD & CEO". www.thehindubusinessline.com. Retrieved 15 March 2022.
Rautela, Isha (14 July 2022). "Syngene inks 10-year biologics manufacturing pact with Zoetis". www.thehindubusinessline.com. Retrieved 17 July 2022.

web.archive.org

"Biocon Annual Report, 2010" (PDF). Archived from the original (PDF) on 26 October 2010. Retrieved 20 September 2010.
Biocon Website ("Biocon - Biosimilars, Fermentation, Oral Insulin, Human Insulin, Immunosuppresants, Monoclonal Antibody, Recombinant Proteins, Biopharmaceutical, Biotechnology Company, EGFR, GCSF, Fermentation, Orlistat, Insulin Glargine, Insulin Lispro, Peptides, Insulin Aspart". Archived from the original on 7 August 2014. Retrieved 3 August 2014.)

wipo.int

"Building on a Foundation of IP". www.wipo.int. Retrieved 20 March 2023.

worldcat.org

search.worldcat.org

Plum-Mörschel, Leona; Singh, Gursharan; Murugesan, Sundara Moorthi Nainar; Marwah, Ashwani; Panda, Jayanti; Loganathan, Subramanian; Athalye, Sandeep N. (2022). "Pharmacokinetic and pharmacodynamic equivalence of Biocon's biosimilar Insulin-R with the US -licensed Humulin® R formulation in healthy subjects: Results from the RHINE -1 ( Recombinant Human INsulin Equivalence-1 ) study". Diabetes, Obesity and Metabolism. 24 (4): 713–721. doi:10.1111/dom.14635. ISSN 1462-8902. PMC 9303355. PMID 34981621.
"Atlas Copco sells majority stake in rental business". Pump Industry Analyst. 2006 (10): 12. 29 October 2006. doi:10.1016/s1359-6128(06)71621-4. ISSN 1359-6128.